Does NARATRIPTAN Cause Neovascularisation? 59 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Neovascularisation have been filed in association with NARATRIPTAN (Naratriptan). This represents 11.2% of all adverse event reports for NARATRIPTAN.
59
Reports of Neovascularisation with NARATRIPTAN
11.2%
of all NARATRIPTAN reports
0
Deaths
0
Hospitalizations
How Dangerous Is Neovascularisation From NARATRIPTAN?
Of the 59 reports.
Is Neovascularisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NARATRIPTAN. However, 59 reports have been filed with the FAERS database.
What Other Side Effects Does NARATRIPTAN Cause?
Drug ineffective (186)
Migraine (111)
Nausea (87)
Dyspnoea (82)
Treatment failure (79)
Diarrhoea (76)
Cough (72)
Weight decreased (71)
Abdominal pain (65)
Dyspepsia (60)
What Other Drugs Cause Neovascularisation?
LAMOTRIGINE (62)
PREDNISONE (60)
PROPRANOLOL (60)
AMLODIPINE (59)
ATENOLOL (59)
DIHYDROERGOTAMINE (59)
GABAPENTIN (59)
METOCLOPRAMIDE (59)
NADOLOL (59)
NAPROXEN (59)
Which NARATRIPTAN Alternatives Have Lower Neovascularisation Risk?
NARATRIPTAN vs NASONEX
NARATRIPTAN vs NATALIZUMAB
NARATRIPTAN vs NATALIZUMAB-SZTN
NARATRIPTAN vs NATAMYCIN
NARATRIPTAN vs NATEGLINIDE